ADHD Trial, Recruiting (NCT05728840)

ADHD Trial, Recruiting NCT05728840 Sponsor: Mindmaze SA Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT05728840 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The stroke must have occurred less than 1 month ago
Testing during a standard brain assessment must show measurable problems with attention
A brain scan (CT or MRI) must confirm a brain injury
The person must be able to give their own consent by signing a form
The person must be 18 years old or older

Who may not be able to join:

People who have epilepsy
People who are unable to take part in the specific treatment being studied, or for whom it would be medically unsafe to do so
People who have a significant pre-existing psychiatric condition
People who have major thinking or memory problems, such as dementia
People who cannot tell colours apart
People whose overall thinking and understanding is too affected to follow and complete the tasks involved in the trial
People who do not wish to be told if something unexpected is found during the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sonia Crottaz-Herbette, University of Lausanne Hospitals

Phone: +41213149348

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05728840

Sponsor: Mindmaze SA

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: +41213149348

More information: https://clinicaltrials.gov/study/NCT05728840

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The stroke must have occurred less than 1 month ago
Testing during a standard brain assessment must show measurable problems with attention
A brain scan (CT or MRI) must confirm a brain injury
The person must be able to give their own consent by signing a form
The person must be 18 years old or older

Who may not be able to join:

People who have epilepsy
People who are unable to take part in the specific treatment being studied, or for whom it would be medically unsafe to do so
People who have a significant pre-existing psychiatric condition
People who have major thinking or memory problems, such as dementia
People who cannot tell colours apart
People whose overall thinking and understanding is too affected to follow and complete the tasks involved in the trial
People who do not wish to be told if something unexpected is found during the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mindmaze SA

Registry

ClinicalTrials.gov

Start date

15 February 2023

Est. completion

31 July 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Change from baseline in Test of Attentional Performance (TAP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov